SlideShare a Scribd company logo
1 of 11
Schizophrenia
• Schizophrenia is a mental disorder characterized
by abnormal social behavior and failure to recognize what
is real. Common symptoms include false beliefs, unclear or
confused thinking, hearing voices, reduced social engagement
and emotional expression, and a lack of motivation.
• People often have additional mental health problems such
as major depression, anxiety disorders, or substance use
disorder. Symptoms typically come on gradually, begin in young
adulthood, and last a long time.
• The cause of schizophrenia is believed to be a combination
of genetic and environmental factors. Possible environmental
factors include cannabis use, poor nutrition during pregnancy,
being raised in a city, parental care, and certain infections.
Self-portrait of a person with schizophrenia, representing that individual's
perception of the distorted experience of reality in the disorder
• Schizophrenia occurs with regular frequency nearly everywhere in the
world in 1 % of population and begins mainly in young age (mostly around
16 to 25 years).
• Schizophrenia is often described in terms of positive and negative (or
deficit) symptoms.
• Positive symptoms are those that most individuals do not normally
experience but are present in people with schizophrenia. They can include
delusions, disordered thoughts and speech
and tactile, auditory, visual, olfactory and gustatory hallucinations, typically
regarded as manifestations of psychosis. Positive symptoms generally
respond well to medication.
• Negative symptoms are deficits of normal emotional responses or of other
thought processes, and are less responsive to medication. They commonly
include flat expressions or little emotion, poverty of speech, inability to
experience pleasure, lack of desire to form relationships, and lack of
motivation. Negative symptoms appear to contribute more to poor quality
of life, functional ability, and the burden on others than do positive
symptoms. People with greater negative symptoms often have a history of
poor adjustment before the onset of illness, and response to medication is
often limited.
My eyes at the moment of the apparitions by German
artist August Natterer who had schizophrenia
Cause and pathogenesis
• A combination of genetic and environmental factors play a role in the development of
schizophrenia. People with a family history of schizophrenia who have a transient
psychosis have a 20–40% chance of being diagnosed one year later.
• A number of attempts have been made to explain the link between altered brain
function and schizophrenia. One of the most common is the dopamine hypothesis, which
attributes psychosis to the mind's faulty interpretation of the misfiring of dopaminergic
neurons.
• The dopamine hypothesis of schizophrenia or the dopamine hypothesis of psychosis is
a model, attributing symptoms of schizophrenia (like psychoses) to a disturbed and
hyperactive dopaminergic signal transduction. The model draws evidence from the
observation that a large number of antipsychotics have dopamine-receptor antagonistic
effects. The theory, however, does not say dopamine overabundance as a complete
explanation for schizophrenia. Rather, the over activation of D2 receptors is one of the
reason for this disorder.
• Psychotic symptoms are related to dopaminergic hyperactivity in the brain. Hyperactivity
of dopaminergic systems during schizophrenia is result of increased sensitivity and
density of dopamine D2 receptors in the different parts of the brain.
Cloth embroidered by a person diagnosed with
schizophrenia
Diagnostic Process for Schizophrenia
• Imaging (CT, MRI, PET) are seldom helpful in diagnosis.
• The diagnosis is commonly made from history and the mental status
exam.
• There are currently no reliable biomarkers for diagnosis or severity.
Pharmacological Treatment of Acute
Schizophrenia
• Antipsychotic medications are effective for decreasing the severity of
psychotic symptoms. E.g. Chlorpromazine, haloperidol.
• Nearly all patients on antipsychotic medications will experience some
burden from side effects such as Blurred vision, Dry mouth,
Drowsiness, Muscle spasms or tremors, Weight gain.
• Antipsychotics are relatively ineffective for negative symptoms and
cognitive impairment.
Long-term treatment of schizophrenia
• Antipsychotic medications are effective for preventing relapse
in stabilized patients
• Effective no pharmacological treatments include patient and
family education, skills training, supported employment,
cognitive behavior therapies, and psychotherapies
• For most individuals, antipsychotic medications control the
symptoms while non-pharmacological treatments address the
impairments in social, vocational, and educational
functioning
John Nash, an American mathematician and joint winner of the 1994 Nobel
Prize for Economics, who had schizophrenia. His life was the subject of the
2001 Academy Award-winning film A Beautiful Mind.

More Related Content

What's hot (20)

NEUROPSYCHIATRIC ASPECTS OF BRAIN TUMORS.pptx
NEUROPSYCHIATRIC ASPECTS OF BRAIN TUMORS.pptxNEUROPSYCHIATRIC ASPECTS OF BRAIN TUMORS.pptx
NEUROPSYCHIATRIC ASPECTS OF BRAIN TUMORS.pptx
 
Bipolar
BipolarBipolar
Bipolar
 
Anxiety Disorders
Anxiety DisordersAnxiety Disorders
Anxiety Disorders
 
Psychotic disorders
Psychotic disordersPsychotic disorders
Psychotic disorders
 
Neurobiology of schizophrenia
Neurobiology of schizophreniaNeurobiology of schizophrenia
Neurobiology of schizophrenia
 
Etiology of Schizophrenia
Etiology of Schizophrenia Etiology of Schizophrenia
Etiology of Schizophrenia
 
Anxiety disorders
Anxiety disordersAnxiety disorders
Anxiety disorders
 
Anxiety Disorder: Symptoms, Diagnostic Criteria N Treatment
Anxiety Disorder: Symptoms, Diagnostic Criteria N Treatment Anxiety Disorder: Symptoms, Diagnostic Criteria N Treatment
Anxiety Disorder: Symptoms, Diagnostic Criteria N Treatment
 
Neuropsychiatric aspects of epilepsy
Neuropsychiatric aspects of epilepsyNeuropsychiatric aspects of epilepsy
Neuropsychiatric aspects of epilepsy
 
Schizophrenia
SchizophreniaSchizophrenia
Schizophrenia
 
Mental Disorder W
Mental Disorder WMental Disorder W
Mental Disorder W
 
Psychotic Disorders
Psychotic DisordersPsychotic Disorders
Psychotic Disorders
 
Neurobiology of substance dependence
Neurobiology of substance dependenceNeurobiology of substance dependence
Neurobiology of substance dependence
 
Schizoaffective disorder DSM5
Schizoaffective  disorder DSM5Schizoaffective  disorder DSM5
Schizoaffective disorder DSM5
 
Schizophrenia
SchizophreniaSchizophrenia
Schizophrenia
 
Mood disorders, Psych II
Mood disorders, Psych IIMood disorders, Psych II
Mood disorders, Psych II
 
H
HH
H
 
Anxiety disorders DSM-5
Anxiety disorders DSM-5Anxiety disorders DSM-5
Anxiety disorders DSM-5
 
Neuropsychiatric aspects of epilepsy osmanali
Neuropsychiatric aspects of epilepsy osmanaliNeuropsychiatric aspects of epilepsy osmanali
Neuropsychiatric aspects of epilepsy osmanali
 
What is bipolar disorder
What is bipolar disorderWhat is bipolar disorder
What is bipolar disorder
 

Similar to SCHIZOPHRENIA.pptx

Similar to SCHIZOPHRENIA.pptx (20)

Schizophrenia
SchizophreniaSchizophrenia
Schizophrenia
 
Schizophrenia pathophysiology
Schizophrenia  pathophysiologySchizophrenia  pathophysiology
Schizophrenia pathophysiology
 
Schizophrenia
SchizophreniaSchizophrenia
Schizophrenia
 
Schizophrenia
SchizophreniaSchizophrenia
Schizophrenia
 
Schizophrenia health center
Schizophrenia health centerSchizophrenia health center
Schizophrenia health center
 
Schizophrenia
SchizophreniaSchizophrenia
Schizophrenia
 
pharmacotherapy of Schizophrenia
pharmacotherapy of Schizophreniapharmacotherapy of Schizophrenia
pharmacotherapy of Schizophrenia
 
Pharmacotherapy of Schizophrenia
Pharmacotherapy of SchizophreniaPharmacotherapy of Schizophrenia
Pharmacotherapy of Schizophrenia
 
Schizophrenia
SchizophreniaSchizophrenia
Schizophrenia
 
SCHIZOPHRENIA.pptx.pdf
 SCHIZOPHRENIA.pptx.pdf SCHIZOPHRENIA.pptx.pdf
SCHIZOPHRENIA.pptx.pdf
 
Schizophrenia
SchizophreniaSchizophrenia
Schizophrenia
 
Specific disorder and Treatment
Specific disorder and TreatmentSpecific disorder and Treatment
Specific disorder and Treatment
 
Schizophrenia
Schizophrenia Schizophrenia
Schizophrenia
 
Schizophrenia and other Psychotic disorders.pptx
Schizophrenia and other Psychotic disorders.pptxSchizophrenia and other Psychotic disorders.pptx
Schizophrenia and other Psychotic disorders.pptx
 
Schizophrenia.pptx
Schizophrenia.pptxSchizophrenia.pptx
Schizophrenia.pptx
 
SCHIZOPHRENIA.pptx
SCHIZOPHRENIA.pptxSCHIZOPHRENIA.pptx
SCHIZOPHRENIA.pptx
 
antipsychotics.pdf
antipsychotics.pdfantipsychotics.pdf
antipsychotics.pdf
 
schizophrenia
schizophreniaschizophrenia
schizophrenia
 
Schiz.ppt
Schiz.pptSchiz.ppt
Schiz.ppt
 
Chapter14
Chapter14Chapter14
Chapter14
 

More from DinamGyatsoAadHenmoo

More from DinamGyatsoAadHenmoo (20)

Pharmacology of Antianginal Drug, B.sc Nursing
Pharmacology of Antianginal Drug, B.sc NursingPharmacology of Antianginal Drug, B.sc Nursing
Pharmacology of Antianginal Drug, B.sc Nursing
 
Adrenergic drugs.pptx
Adrenergic drugs.pptxAdrenergic drugs.pptx
Adrenergic drugs.pptx
 
03-anti-cholinergicsmbbs-160320071438.pptx
03-anti-cholinergicsmbbs-160320071438.pptx03-anti-cholinergicsmbbs-160320071438.pptx
03-anti-cholinergicsmbbs-160320071438.pptx
 
GENERAL PHARMACOLOGY.pptx
GENERAL PHARMACOLOGY.pptxGENERAL PHARMACOLOGY.pptx
GENERAL PHARMACOLOGY.pptx
 
urine analysis.pptx
urine analysis.pptxurine analysis.pptx
urine analysis.pptx
 
hairdruganalysisppt-200329061013.pptx
hairdruganalysisppt-200329061013.pptxhairdruganalysisppt-200329061013.pptx
hairdruganalysisppt-200329061013.pptx
 
Zinc poisoning.pptx
Zinc poisoning.pptxZinc poisoning.pptx
Zinc poisoning.pptx
 
MERCURY POISONING.pptx
MERCURY POISONING.pptxMERCURY POISONING.pptx
MERCURY POISONING.pptx
 
LEAD POISONING.pptx
LEAD POISONING.pptxLEAD POISONING.pptx
LEAD POISONING.pptx
 
49_CLASSIFICATION OF TOXICANTS.pptx
49_CLASSIFICATION OF TOXICANTS.pptx49_CLASSIFICATION OF TOXICANTS.pptx
49_CLASSIFICATION OF TOXICANTS.pptx
 
ADRENOCORTICOTROPHIC HORMONE.pptx
ADRENOCORTICOTROPHIC HORMONE.pptxADRENOCORTICOTROPHIC HORMONE.pptx
ADRENOCORTICOTROPHIC HORMONE.pptx
 
LIVER CIRRHOSIS.pptx
LIVER CIRRHOSIS.pptxLIVER CIRRHOSIS.pptx
LIVER CIRRHOSIS.pptx
 
allergicrhinitis-140911185124-phpapp01.pptx
allergicrhinitis-140911185124-phpapp01.pptxallergicrhinitis-140911185124-phpapp01.pptx
allergicrhinitis-140911185124-phpapp01.pptx
 
growthhormone-180426100028.pptx
growthhormone-180426100028.pptxgrowthhormone-180426100028.pptx
growthhormone-180426100028.pptx
 
systemiclupuserythematosus-180125101602.pptx
systemiclupuserythematosus-180125101602.pptxsystemiclupuserythematosus-180125101602.pptx
systemiclupuserythematosus-180125101602.pptx
 
Bone_DDS_Part_I.pdf
Bone_DDS_Part_I.pdfBone_DDS_Part_I.pdf
Bone_DDS_Part_I.pdf
 
DIABETES.pptx
DIABETES.pptxDIABETES.pptx
DIABETES.pptx
 
Atherosclerosis.pptx
Atherosclerosis.pptxAtherosclerosis.pptx
Atherosclerosis.pptx
 
TQM.pptx
TQM.pptxTQM.pptx
TQM.pptx
 
CT.pptx
CT.pptxCT.pptx
CT.pptx
 

Recently uploaded

On National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsOn National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsMebane Rash
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfagholdier
 
Unit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptxUnit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptxVishalSingh1417
 
How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17Celine George
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104misteraugie
 
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...Shubhangi Sonawane
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Celine George
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeThiyagu K
 
Energy Resources. ( B. Pharmacy, 1st Year, Sem-II) Natural Resources
Energy Resources. ( B. Pharmacy, 1st Year, Sem-II) Natural ResourcesEnergy Resources. ( B. Pharmacy, 1st Year, Sem-II) Natural Resources
Energy Resources. ( B. Pharmacy, 1st Year, Sem-II) Natural ResourcesShubhangi Sonawane
 
ICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxAreebaZafar22
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactPECB
 
Food Chain and Food Web (Ecosystem) EVS, B. Pharmacy 1st Year, Sem-II
Food Chain and Food Web (Ecosystem) EVS, B. Pharmacy 1st Year, Sem-IIFood Chain and Food Web (Ecosystem) EVS, B. Pharmacy 1st Year, Sem-II
Food Chain and Food Web (Ecosystem) EVS, B. Pharmacy 1st Year, Sem-IIShubhangi Sonawane
 
Seal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxSeal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxnegromaestrong
 
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...Nguyen Thanh Tu Collection
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfAdmir Softic
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingTechSoup
 
ComPTIA Overview | Comptia Security+ Book SY0-701
ComPTIA Overview | Comptia Security+ Book SY0-701ComPTIA Overview | Comptia Security+ Book SY0-701
ComPTIA Overview | Comptia Security+ Book SY0-701bronxfugly43
 
General Principles of Intellectual Property: Concepts of Intellectual Proper...
General Principles of Intellectual Property: Concepts of Intellectual  Proper...General Principles of Intellectual Property: Concepts of Intellectual  Proper...
General Principles of Intellectual Property: Concepts of Intellectual Proper...Poonam Aher Patil
 

Recently uploaded (20)

On National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsOn National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan Fellows
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdf
 
Unit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptxUnit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptx
 
How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104
 
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and Mode
 
Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024
 
Energy Resources. ( B. Pharmacy, 1st Year, Sem-II) Natural Resources
Energy Resources. ( B. Pharmacy, 1st Year, Sem-II) Natural ResourcesEnergy Resources. ( B. Pharmacy, 1st Year, Sem-II) Natural Resources
Energy Resources. ( B. Pharmacy, 1st Year, Sem-II) Natural Resources
 
ICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptx
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global Impact
 
Food Chain and Food Web (Ecosystem) EVS, B. Pharmacy 1st Year, Sem-II
Food Chain and Food Web (Ecosystem) EVS, B. Pharmacy 1st Year, Sem-IIFood Chain and Food Web (Ecosystem) EVS, B. Pharmacy 1st Year, Sem-II
Food Chain and Food Web (Ecosystem) EVS, B. Pharmacy 1st Year, Sem-II
 
Seal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxSeal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptx
 
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdf
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy Consulting
 
ComPTIA Overview | Comptia Security+ Book SY0-701
ComPTIA Overview | Comptia Security+ Book SY0-701ComPTIA Overview | Comptia Security+ Book SY0-701
ComPTIA Overview | Comptia Security+ Book SY0-701
 
General Principles of Intellectual Property: Concepts of Intellectual Proper...
General Principles of Intellectual Property: Concepts of Intellectual  Proper...General Principles of Intellectual Property: Concepts of Intellectual  Proper...
General Principles of Intellectual Property: Concepts of Intellectual Proper...
 
Asian American Pacific Islander Month DDSD 2024.pptx
Asian American Pacific Islander Month DDSD 2024.pptxAsian American Pacific Islander Month DDSD 2024.pptx
Asian American Pacific Islander Month DDSD 2024.pptx
 

SCHIZOPHRENIA.pptx

  • 2. • Schizophrenia is a mental disorder characterized by abnormal social behavior and failure to recognize what is real. Common symptoms include false beliefs, unclear or confused thinking, hearing voices, reduced social engagement and emotional expression, and a lack of motivation. • People often have additional mental health problems such as major depression, anxiety disorders, or substance use disorder. Symptoms typically come on gradually, begin in young adulthood, and last a long time. • The cause of schizophrenia is believed to be a combination of genetic and environmental factors. Possible environmental factors include cannabis use, poor nutrition during pregnancy, being raised in a city, parental care, and certain infections.
  • 3. Self-portrait of a person with schizophrenia, representing that individual's perception of the distorted experience of reality in the disorder
  • 4. • Schizophrenia occurs with regular frequency nearly everywhere in the world in 1 % of population and begins mainly in young age (mostly around 16 to 25 years). • Schizophrenia is often described in terms of positive and negative (or deficit) symptoms. • Positive symptoms are those that most individuals do not normally experience but are present in people with schizophrenia. They can include delusions, disordered thoughts and speech and tactile, auditory, visual, olfactory and gustatory hallucinations, typically regarded as manifestations of psychosis. Positive symptoms generally respond well to medication. • Negative symptoms are deficits of normal emotional responses or of other thought processes, and are less responsive to medication. They commonly include flat expressions or little emotion, poverty of speech, inability to experience pleasure, lack of desire to form relationships, and lack of motivation. Negative symptoms appear to contribute more to poor quality of life, functional ability, and the burden on others than do positive symptoms. People with greater negative symptoms often have a history of poor adjustment before the onset of illness, and response to medication is often limited.
  • 5. My eyes at the moment of the apparitions by German artist August Natterer who had schizophrenia
  • 6. Cause and pathogenesis • A combination of genetic and environmental factors play a role in the development of schizophrenia. People with a family history of schizophrenia who have a transient psychosis have a 20–40% chance of being diagnosed one year later. • A number of attempts have been made to explain the link between altered brain function and schizophrenia. One of the most common is the dopamine hypothesis, which attributes psychosis to the mind's faulty interpretation of the misfiring of dopaminergic neurons. • The dopamine hypothesis of schizophrenia or the dopamine hypothesis of psychosis is a model, attributing symptoms of schizophrenia (like psychoses) to a disturbed and hyperactive dopaminergic signal transduction. The model draws evidence from the observation that a large number of antipsychotics have dopamine-receptor antagonistic effects. The theory, however, does not say dopamine overabundance as a complete explanation for schizophrenia. Rather, the over activation of D2 receptors is one of the reason for this disorder. • Psychotic symptoms are related to dopaminergic hyperactivity in the brain. Hyperactivity of dopaminergic systems during schizophrenia is result of increased sensitivity and density of dopamine D2 receptors in the different parts of the brain.
  • 7. Cloth embroidered by a person diagnosed with schizophrenia
  • 8. Diagnostic Process for Schizophrenia • Imaging (CT, MRI, PET) are seldom helpful in diagnosis. • The diagnosis is commonly made from history and the mental status exam. • There are currently no reliable biomarkers for diagnosis or severity.
  • 9. Pharmacological Treatment of Acute Schizophrenia • Antipsychotic medications are effective for decreasing the severity of psychotic symptoms. E.g. Chlorpromazine, haloperidol. • Nearly all patients on antipsychotic medications will experience some burden from side effects such as Blurred vision, Dry mouth, Drowsiness, Muscle spasms or tremors, Weight gain. • Antipsychotics are relatively ineffective for negative symptoms and cognitive impairment.
  • 10. Long-term treatment of schizophrenia • Antipsychotic medications are effective for preventing relapse in stabilized patients • Effective no pharmacological treatments include patient and family education, skills training, supported employment, cognitive behavior therapies, and psychotherapies • For most individuals, antipsychotic medications control the symptoms while non-pharmacological treatments address the impairments in social, vocational, and educational functioning
  • 11. John Nash, an American mathematician and joint winner of the 1994 Nobel Prize for Economics, who had schizophrenia. His life was the subject of the 2001 Academy Award-winning film A Beautiful Mind.